Trial intelligence / Profile preview

IVIG prevention of BK virus viremia after kidney transplantation

2018-000695-15Phase 3Active

Sponsor
Strasbourg University Hospital
Start
Jan 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of immune globulin in BK polyomavirus infection, sponsored by Strasbourg University Hospital. Primary endpoint: Incidence of BK virus viremia at 6 months. Started Jan 2020; status: active.

02

Drugs

immune globulin
03

Conditions

BK polyomavirus infection

Beyond the preview

Go deeper on 2018-000695-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000695-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call